Source - LSE Regulatory
RNS Number : 9631M
Aminex PLC
27 January 2021

27 January 2021


Aminex plc

 ("Aminex" or "the Company")


Notice of Extraordinary General Meeting


An extraordinary general meeting of the Company will be held at Kings Buildings, 16 Smith Square, London SW1P 3JJ on 18 February 2021 at 10.00 am (the "EGM").

The business of the EGM will be to consider and, if thought fit, approve certain resolutions relating to the replacement of CREST with a system operated by Euroclear Bank SA/NV for the electronic settlement of trading in the Company's ordinary shares (the "Migration").

As a result of the withdrawal of the United Kingdom from the European Union, the CREST settlement system will soon no longer be able to provide settlement services to Irish incorporated listed companies.  Approval of the resolutions is therefore necessary to ensure that the Company's shares can continue to be held and settled electronically when they are traded on the London Stock Exchange and remain eligible for continued admission to trading and listing on that exchange, which is crucial to the interests of the Company and its shareholders as a whole. There is no meaningful alternative to Migration and failure to migrate would remove the Company's access to electronic trade settlement.

The circular which includes notice of the EGM (the "Circular") and a Form of Proxy is being posted to shareholders today. The Board strongly urges shareholders to review the contents of the Circular in their entirety, including the documents referred to therein, and consider the Board's recommendation to vote in favour of the Resolutions.

The Circular, the Form of Proxy and copies of the documents referred to in the Circular are available to view on the Company's website, and will be available for inspection as described in the Circular. However, due to Covid-19 public health guidelines, shareholders are advised to view the documents on the website.

EGM arrangements and Covid-19

The Company will follow public health guidelines in respect of social distancing, mass gatherings and other measures taken regarding Covid-19. The Company will be implementing the relevant measures advised by UK Government agencies at the EGM in relation to Covid-19. The wellbeing of our shareholders, staff and others are our priority. It is the Company's intention to hold the EGM with the minimum quorum necessary and we strongly advise our shareholders to submit their forms of proxy by post or electronically to ensure their vote counts at the EGM given that personal attendance at the EGM is not recommended under current Government guidelines. The Company reserves the right to refuse entry to the meeting where reasonably necessary to comply with the Covid-19 related public health measures and advice. We would therefore recommend that you consider appointing the chairperson of the EGM as your proxy due to the restrictions on other persons attending the EGM.

The Company will continue to closely monitor the developing situation around Covid-19, including the latest UK Government guidance, and how this may affect the arrangements for the EGM. Consequently, the EGM is subject to change, possibly at short notice. If it becomes necessary or appropriate to revise the current arrangements for the EGM, further information will be made available as quickly as possible by RNS and on our website at

Further information in relation to the EGM 

In accordance with the Listing Rules of the Financial Conduct Authority, copies of the Circular and the Articles of Association as they are proposed to be amended have been submitted to the UK National Storage Mechanism and will shortly be available for inspection at:



For further information:


Aminex PLC 





+44 20 3198 8415 

Robert Ambrose, CEO

Charles Santos, Chairman




+353 1 679 6363 

Brian Garrahy 





+44 20 3781 8331 

Billy Clegg / James Crothers / Daniel Sherwen 




This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact or visit

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account.